Does DALBAVANCIN Cause Agranulocytosis? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Agranulocytosis have been filed in association with DALBAVANCIN (DALBAVANCIN HYDROCHLORIDE). This represents 0.5% of all adverse event reports for DALBAVANCIN.
5
Reports of Agranulocytosis with DALBAVANCIN
0.5%
of all DALBAVANCIN reports
0
Deaths
3
Hospitalizations
How Dangerous Is Agranulocytosis From DALBAVANCIN?
Of the 5 reports, 3 (60.0%) required hospitalization.
Is Agranulocytosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DALBAVANCIN. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does DALBAVANCIN Cause?
Off label use (192)
Rash (99)
Pruritus (64)
Dyspnoea (62)
Back pain (61)
Erythema (56)
Vomiting (54)
Hypersensitivity (49)
Nausea (45)
Drug ineffective (44)
What Other Drugs Cause Agranulocytosis?
CLOZAPINE (1,766)
CYCLOPHOSPHAMIDE (1,242)
RITUXIMAB (1,154)
SULFAMETHOXAZOLE\TRIMETHOPRIM (797)
PANTOPRAZOLE (599)
METHOTREXATE (550)
SODIUM (549)
EPIRUBICIN (491)
METAMIZOLE (438)
DOCETAXEL (436)
Which DALBAVANCIN Alternatives Have Lower Agranulocytosis Risk?
DALBAVANCIN vs DALFAMPRIDINE
DALBAVANCIN vs DALTEPARIN
DALBAVANCIN vs DAMOCTOCOG ALFA PEGOL
DALBAVANCIN vs DANAPAROID
DALBAVANCIN vs DANAZOL